Riskpilot← Back to searchSign inGet full accessMathiesen Medical Jonstorp AB
ABActiveOrg 5566067087Lyckerisvägen 73Research and experimental development on natural sciences and engineering · NACE 7210Est. 20010 employees
Revenue 2025
SEK 0
EBITDA margin
—
-64% vs 2025
Equity ratio
92.1%
Financial strength
Net profit 2025
SEK 147K
+153% vs 2025
| Revenue | SEK 0 | — |
| EBITDA | SEK -30K | -64% |
| Net profit | SEK 147K | +153% |
| Total assets | SEK 1,7M | +1% |
| Equity | SEK 1,6M | +10% |
| Employees | 0 | — |
Legal name
Mathiesen Medical Jonstorp AB
Org number
5566067087
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12 april 2001
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva medicinsk praktik, utveckling och konsultverksamhet och därmed förenlig verksamhet.
Address
Lyckerisvägen 73
Email
toomasm@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 7 | 0 |
| Staff expenses | −6 | −5 | −6 | −0 | −0 |
| EBITDA | −64 | −66 | −177 | −18 | −30 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | −64 | −66 | −177 | −18 | −30 |
| Net financials | 159 | 0 | −0 | 117 | 86 |
| Profit before tax | 151 | 94 | 20 | 74 | 185 |
| Tax | −33 | −24 | −8 | −16 | −38 |
| Net profit | 118 | 70 | 11 | 58 | 147 |
| Item | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 032 | 1 920 | 1 808 | 1 676 | 1 697 |
| Equity | 1 278 | 1 348 | 1 359 | 1 417 | 1 564 |
| Long-term debt | — | — | — | — | — |
| Short-term debt | 293 | 271 | 344 | 130 | 133 |
| Total debt | 293 | 271 | 344 | 130 | 133 |
EBITDA margin
-3016800.0%
This company
15.8%
Market median
-19093771% vs market
20222025
Equity ratio
92.1%
This company
38.2%
Market median
+141% vs market
20222025
Return on equity
9.4%
This company
18.4%
Market median
-49% vs market
20222025
Net profit margin
14650000.0%
This company
8.1%
Market median
+180864098% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-07-01 – 2025-12-31
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mathiesen Medical Jonstorp AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Christina Brattström | Deputy Board Member | 0 companies |
| Carin Märta Maria Mathiesen | Deputy Board Member | 0 companies |
| Tiit Illimar Mathiesen | Board of Directors | 0 companies |
| Toomas Indrek Mathiesen | Board of Directors | 0 companies |